Dutton Associates updates its coverage of Familymeds Group, Inc. (Nasdaq:FMRX), maintaining its Speculative Buy rating and a 12-month price target of $6.25. The 9-page report by Dutton Associates senior analyst Jonathan H. Ziegler, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, and Knobias and other leading financial portals.

Familymeds Group, a pharmacy and medical specialty product provider, reported strong comparable store sales of 10.8% for the third quarter ending September 30, 2006. Another encouraging development was the November 9, 2006 announcement that its third Worksite Pharmacy will open on January 2, 2007. It will exclusively service Toyota team members, participating on-site suppliers and their dependents at the site of Toyota's newly constructed plant in San Antonio.

About Dutton Associates

Dutton Associates is one of the largest independent investment research firms in the U.S. Its 28 senior analysts are primarily CFAs, and have expertise in many industries. Dutton Associates provides continuing analyst coverage of 140 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors.

The current cost of enrollment in our one-year continuing research program is US $39,500 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $33,000 from the Company for 2 Research Reports with coverage commencing on 09/19/06. The Firm does not accept any equity compensation. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.